Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Influenza

Free Subscription 28.01.2019 2 Arch Virol 1 J Gen Virol 1 J Infect 4 J Virol 1 J Virol Methods 4 Lancet Respir Med 1 MMWR Morb Mortal Wkly Rep 1 PLoS Comput Biol 1 PLoS One 5 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Arch Virol

1. WEI X, Liu Z, Wang J, Yang R, et al
   The interaction of cellular protein ANP32A with influenza A virus polymerase component PB2 promotes vRNA synthesis.
   Arch Virol. 2019 Jan 21. pii: 10.1007/s00705-018-04139.
   PubMed     Text format     Abstract available
   
   
2. HU J, Liang Y, Hu Z, Wang X, et al
   Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens.
   Arch Virol. 2019 Jan 22. pii: 10.1007/s00705-018-04142.
   PubMed     Text format     Abstract available
   
   

   
   J Gen Virol

3. JAMES J, Smith N, Ross C, Iqbal M, et al
   The cellular localization of avian influenza virus PB1-F2 protein alters the magnitude of IFN2 promoter and NFkappaB-dependent promoter antagonism in chicken cells.
   J Gen Virol. 2019 Jan 23. doi: 10.1099/jgv.0.001220.
   PubMed     Text format     Abstract available
   
   

   
   J Infect

4. YANG Y, Wong G, Yang L, Tan S, et al
   Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: clinical and virological findings.
   J Infect. 2019 Jan 18. pii: S0163-4453(19)30024.
   PubMed     Text format     Abstract available
   
   

   
   J Virol

5. SALEM E, Hagglund S, Cassard H, Corre T, et al
   Pathogenesis, host innate immune response and aerosol transmission of Influenza D virus in cattle.
   J Virol. 2019 Jan 23. pii: JVI.01853-18. doi: 10.1128/JVI.01853.
   PubMed     Text format     Abstract available
   
   
6. DUBOIS J, Traversier A, Julien T, Padey B, et al
   The non-structural NS1 protein of influenza viruses modulates TP53 splicing through the host factor CPSF4.
   J Virol. 2019 Jan 16. pii: JVI.02168-18. doi: 10.1128/JVI.02168.
   PubMed     Text format     Abstract available
   
   
7. LIANG B, Kabatova B, Kabat J, Dorward DW, et al
   Effects of alterations to the CX3C motif and secreted form of human respiratory syncytial virus (RSV) G protein on immune responses to a parainfluenza virus vector expressing the RSV G protein.
   J Virol. 2019 Jan 16. pii: JVI.02043-18. doi: 10.1128/JVI.02043.
   PubMed     Text format     Abstract available
   
   
8. LIU S, Liu L, Xu G, Cao Z, et al
   Epigenetic modification is regulated by the interaction of influenza A virus nonstructural protein-1 with the de novo DNA methyltransferase DNMT3B and subsequent transport to the cytoplasm for K48-linked polyubiquitination.
   J Virol. 2019 Jan 16. pii: JVI.01587-18. doi: 10.1128/JVI.01587.
   PubMed     Text format     Abstract available
   
   

   
   J Virol Methods

9. WUTHRICH D, Lang D, Muller NF, Neher RA, et al
   Evaluation of two workflows for whole genome sequencing-based typing of influenza A viruses.
   J Virol Methods. 2019 Jan 21. pii: S0166-0934(18)30496.
   PubMed     Text format     Abstract available
   
   

   
   Lancet Respir Med

10. SCHELTEMA NM, Nibbelke EE, Pouw J, Blanken MO, et al
    RSV prevention in infancy and asthma in later life - Authors' reply.
    Lancet Respir Med. 2018;6:e33.
    PubMed     Text format    
    
    
11. SIMOES EAF, Liu AH
    RSV prevention in infancy and asthma in later life.
    Lancet Respir Med. 2018;6:e30.
    PubMed     Text format    
    
    
12. CARBONELL-ESTRANY X
    RSV prevention in infancy and asthma in later life.
    Lancet Respir Med. 2018;6:e31.
    PubMed     Text format    
    
    
13. DUPONT W, Wu P, Gebretsadik T, Hartert T, et al
    RSV prevention in infancy and asthma in later life.
    Lancet Respir Med. 2018;6:e32.
    PubMed     Text format    
    
    

    
    MMWR Morb Mortal Wkly Rep

14. 
    QuickStats: Percentage* of Adults Aged 18-64 Years Who Had an Influenza Vaccination(dagger) in the Past 12 Months, by Sex and Current Asthma Status( section sign) - National Health Interview Survey,( paragraph sign) 2017.
    MMWR Morb Mortal Wkly Rep. 2019;68:48.
    PubMed     Text format    
    
    

    
    PLoS Comput Biol

15. YAN AWC, Zaloumis SG, Simpson JA, McCaw JM, et al
    Sequential infection experiments for quantifying innate and adaptive immunity during influenza infection.
    PLoS Comput Biol. 2019;15:e1006568.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

16. ROSANOWSKI SM, Carpenter TE, Adamson D, Rogers CW, et al
    An economic analysis of a contingency model utilising vaccination for the control of equine influenza in a non-endemic country.
    PLoS One. 2019;14:e0210885.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

17. BOCCALINI S, Tacconi FM, Lai PL, Bechini A, et al
    Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy.
    Vaccine. 2019 Jan 14. pii: S0264-410X(19)30026.
    PubMed     Text format     Abstract available
    
    
18. GERRETSEN HE, Capone S, Vitelli A, Reyes LS, et al
    Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection.
    Vaccine. 2018 Oct 11. pii: S0264-410X(18)31351.
    PubMed     Text format     Abstract available
    
    
19. KRAMER R, Duclos A, Lina B, Casalegno JS, et al
    Cost and burden of RSV related hospitalisation from 2012 to 2017 in the first year of life in Lyon, France.
    Vaccine. 2018;36:6591-6593.
    PubMed     Text format     Abstract available
    
    
20. YUNG BS, Pugh H, Generotti AA, Phanhthilath N, et al
    Novel IFN-gamma ELISpot reveals robust T cell responses elicited after influenza nucleoprotein DNA vaccination in New Zealand White rabbits.
    Vaccine. 2019 Jan 17. pii: S0264-410X(19)30037.
    PubMed     Text format     Abstract available
    
    
21. STRIJBOS E, Tannemaat MR, Alleman I, de Meel RHP, et al
    A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis.
    Vaccine. 2019 Jan 16. pii: S0264-410X(19)30038.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: